Cellbricks

Cellbricks is a biofabrication platform for wound healing and reconstruction founded in 2016 by Lutz Kloke, Tobias Lam, Alexander Leutner and Alexander Thomas.

Overview Structured Data Issues Contributors

cellbricks-therapeutics.com

Is a

Company attributes

Industry

Synthetic biology

Tissue engineering

...

Location

B2X

CEO

Simon Mackenzie

Alexander Leutner

Founder

Epoch Biodesign Venture Round, March 2026

Alexander Leutner

Pitchbook URL

pitchbook.com/profiles...327232-81

Number of Employees (Ranges)

11 – 50

Email Address

info@cellbricks.com

Investors

Act Venture Partners

Silicon Roundabout Ventures

Founded Date

2016

Total Funding Amount (USD)

11,600,000

Latest Funding Round Date

March 25, 2026

CTO

Latest Funding Type

Patents Assigned (Count)

1

Country

Headquarters

Other attributes

Company Operating Status

Active

Latest Funding Round Amount (USD)

11,600,000

No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more companies like Cellbricks

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.